rs137852333

Variant summary

Our verdict is Pathogenic. The variant received 17 ACMG points: 17P and 0B. PM1PM2PP2PP3_StrongPP5_Very_Strong

The NM_001360016.2(G6PD):​c.1057C>T​(p.Pro353Ser) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000183 in 1,093,723 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 1 hemizygotes in GnomAD. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Synonymous variant affecting the same amino acid position (i.e. P353P) has been classified as Likely benign.

Frequency

Genomes: not found (cov: 25)
Exomes 𝑓: 0.0000018 ( 0 hom. 1 hem. )

Consequence

G6PD
NM_001360016.2 missense

Scores

9
4
3

Clinical Significance

Pathogenic criteria provided, multiple submitters, no conflicts P:3O:1

Conservation

PhyloP100: 9.39

Publications

7 publications found
Variant links:
Genes affected
G6PD (HGNC:4057): (glucose-6-phosphate dehydrogenase) This gene encodes glucose-6-phosphate dehydrogenase. This protein is a cytosolic enzyme encoded by a housekeeping X-linked gene whose main function is to produce NADPH, a key electron donor in the defense against oxidizing agents and in reductive biosynthetic reactions. G6PD is remarkable for its genetic diversity. Many variants of G6PD, mostly produced from missense mutations, have been described with wide ranging levels of enzyme activity and associated clinical symptoms. G6PD deficiency may cause neonatal jaundice, acute hemolysis, or severe chronic non-spherocytic hemolytic anemia. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
G6PD Gene-Disease associations (from GenCC):
  • anemia, nonspherocytic hemolytic, due to G6PD deficiency
    Inheritance: XL Classification: DEFINITIVE, STRONG Submitted by: ClinGen, Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • G6PD deficiency
    Inheritance: XL Classification: DEFINITIVE Submitted by: ClinGen
  • class I glucose-6-phosphate dehydrogenase deficiency
    Inheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Pathogenic. The variant received 17 ACMG points.

PM1
In a hotspot region, there are 5 aminoacids with missense pathogenic changes in the window of +-8 aminoacids around while only 1 benign, 3 uncertain in NM_001360016.2
PM2
Very rare variant in population databases, with high coverage;
PP2
Missense variant in the gene, where a lot of missense mutations are associated with disease in ClinVar. The gene has 185 curated pathogenic missense variants (we use a threshold of 10). The gene has 42 curated benign missense variants. Gene score misZ: 2.0008 (below the threshold of 3.09). Trascript score misZ: NaN (below the threshold of 3.09). GenCC associations: The gene is linked to anemia, nonspherocytic hemolytic, due to G6PD deficiency, class I glucose-6-phosphate dehydrogenase deficiency, G6PD deficiency.
PP3
MetaRNN computational evidence supports a deleterious effect, 0.993
PP5
Variant X-154532797-G-A is Pathogenic according to our data. Variant chrX-154532797-G-A is described in ClinVar as Pathogenic. ClinVar VariationId is 10385.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
G6PDNM_001360016.2 linkc.1057C>T p.Pro353Ser missense_variant Exon 10 of 13 ENST00000393562.10 NP_001346945.1
G6PDNM_000402.4 linkc.1147C>T p.Pro383Ser missense_variant Exon 10 of 13 NP_000393.4
G6PDNM_001042351.3 linkc.1057C>T p.Pro353Ser missense_variant Exon 10 of 13 NP_001035810.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
G6PDENST00000393562.10 linkc.1057C>T p.Pro353Ser missense_variant Exon 10 of 13 1 NM_001360016.2 ENSP00000377192.3

Frequencies

GnomAD3 genomes
Cov.:
25
GnomAD4 exome
AF:
0.00000183
AC:
2
AN:
1093723
Hom.:
0
Cov.:
33
AF XY:
0.00000278
AC XY:
1
AN XY:
359685
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
26284
American (AMR)
AF:
0.00
AC:
0
AN:
34677
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
19303
East Asian (EAS)
AF:
0.00
AC:
0
AN:
29978
South Asian (SAS)
AF:
0.00
AC:
0
AN:
53617
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
39992
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4129
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
839802
Other (OTH)
AF:
0.0000435
AC:
2
AN:
45941
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.425
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
25
Alfa
AF:
0.00
Hom.:
0

ClinVar

Significance: Pathogenic
Submissions summary: Pathogenic:3Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Anemia, nonspherocytic hemolytic, due to G6PD deficiency Pathogenic:2
Aug 12, 2022
Dunham Lab, University of Washington
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:curation

Variant found in unrelated hemizygotes with deficiency (PS4_M, PP4). Decreased activity in red blood cells (0-5%) (PS3). Predicted to be damaging by SIFT, and probably damaging by PolyPhen (PP3). Not found in gnomAD (PM2). Post_P 0.994 (odds of pathogenicity 1517, Prior_P 0.1).

Apr 27, 2022
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

For these reasons, this variant has been classified as Pathogenic. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt G6PD protein function. ClinVar contains an entry for this variant (Variation ID: 10385). This variant is also known as G6PD Ierapetra. This missense change has been observed in individual(s) with glucose-6-phosphate dehydrogenase deficiency (PMID: 1611091, 10782016). This variant is not present in population databases (gnomAD no frequency). This sequence change replaces proline, which is neutral and non-polar, with serine, which is neutral and polar, at codon 353 of the G6PD protein (p.Pro353Ser).

G6PD deficiency Pathogenic:1
Jul 14, 2023
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant summary: G6PD c.1147C>T (p.Pro383Ser) results in a non-conservative amino acid change located in the C-terminal Glucose-6-phosphate dehydrogenase domain (IPR022675) of the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant was absent in 170326 control chromosomes in gnomAD. c.1147C>T, also described as G6PD Ierapetra, has been reported in the literature in multiple individuals affected with Glucose 6 Phosphate Dehydrogenase Deficiency (example: Menounos_2000, Xu_1995). These data indicate that the variant is likely to be associated with disease. At least one publication reports experimental evidence evaluating an impact on protein function. The most pronounced variant effect results in <10% of normal activity of G6PD (example: Beutler_1992). The following publications have been ascertained in the context of this evaluation (PMID: 1611091, 10782016, 7803800). Three submitters have cited clinical-significance assessments for this variant to ClinVar after 2014 (Pathogenic: n=2; Other per OMIM). Based on the evidence outlined above, the variant was classified as pathogenic.

G6PD IERAPETRA Other:1
May 24, 2017
OMIM
Significance:other
Review Status:no assertion criteria provided
Collection Method:literature only

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.93
BayesDel_addAF
Pathogenic
0.71
D
BayesDel_noAF
Pathogenic
0.78
CADD
Uncertain
24
DANN
Uncertain
1.0
DEOGEN2
Pathogenic
0.99
D;D;D;.
FATHMM_MKL
Uncertain
0.96
D
LIST_S2
Benign
0.0
.;.;D;D
M_CAP
Pathogenic
0.55
D
MetaRNN
Pathogenic
0.99
D;D;D;D
MetaSVM
Pathogenic
0.94
D
MutationAssessor
Pathogenic
4.7
H;H;H;.
PhyloP100
9.4
PrimateAI
Uncertain
0.78
T
PROVEAN
Benign
0.0
.;.;D;D
REVEL
Benign
0.0
Sift
Pathogenic
0.0
.;.;D;D
Sift4G
Uncertain
0.0070
D;.;D;D
Vest4
0.97
ClinPred
1.0
D
GERP RS
5.7
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.2
Varity_R
0.96
gMVP
0.99
Mutation Taster
=1/99
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs137852333; hg19: chrX-153761012; API